Overcoming Persistent AFib Starts with AI Technology.
You’ve tried everything to manage your persistent AFib. Now, there’s a way forward. AI-driven technology is helping electrophysiologists perform more precise ablations—so you can keep moving.
What is AFib—and why does it matter to your health?
Atrial fibrillation (AFib) is an irregular heart rhythm, and is the most common type of irregular heart rhythm1. This common condition can increase your risk of stroke and other serious complications. Learning to recognize the signs and understand how AFib affects your health is the first step toward finding the right next steps—helping you stay in control and live a fuller, healthier life.
A Widespread Condition
More than 37.5M people globally are affected by AFib
Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Stroke. 2021 Feb;16(2):217-221. doi: 10.1177/1747493019897870. Epub 2020 Jan 19. Erratum in: Int J Stroke. 2020 Dec;15(9):NP11-NP12. doi: 10.1177/1747493020905964. PMID: 31955707.
Meaningful Improvements
75% of patients suffer from persistent AFib
Efficacy of Dofetilide in the Treatment of Atrial Fibrillation-Flutter in Patients With Reduced Left Ventricular Function” Ole D. Pedersen, et al
Expert Guidance
Connect with local AFib specialists who are ready to help.
You don’t have to face AFib alone. Our Provider Finder makes it easy to locate professionals who are experienced with our technology—so you can feel confident you’re getting the care you deserve.
Smarter Solutions
Our AI-Powered Approach to Getting Better Outcomes
By blending advanced analytics with clinical expertise, our solution delivers personalized AFib technology that can make measurable progress. Our AI platform offers your healthcare team actionable insights, helping guide each decision and giving you the confidence to move forward in your AFib journey.
Hear from our medical community and patients
“Atrial Fibrillation is the most common heart arrhythmia and can be especially hard-to-treat for the patients experiencing persistent AF. I feel I can offer an option for these tough to treat persistent patients, with a proven clinical benefit.”
